Navigation Links
MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
Date:9/24/2013

SAN DIEGO, Sept. 24, 2013 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of innovative vaccine and antibody based therapies to treat cancer, announces that it has received Contract No. HHSN261201300060C from the National Cancer Institute, National Institutes of Health, under the Small Business Innovation Research Technology Program (SBIR).  The award is in the amount of $1,750,000 over the next three years subject to satisfactory progress and continued availability of funds in the SBIR program.  The grant will support development of a novel positron emission tomography (PET) imaging product for the diagnosis, staging, and treatment assessment of pancreatic cancer.  The product, an antibody fragment linked to a radioactive tracer, is based on the company's discovery of a human antibody designated 5B1 that binds to a cancer antigen expressed on pancreatic cancer.

Pancreatic ductal adenocarcinoma (PDAC or pancreatic cancer) is a leading cause of cancer-related mortality worldwide primarily due in part to late stage diagnosis stemming from the lack of an early diagnostic screening tool.  It is the fourth most common cause of cancer-related death in the United States with 36,800 deaths reported in 2010.  Five-year relative survival rates have changed very little in the last 40 years.

The carbohydrate antigen sialyl-Lewisa (sLea) is expressed on pancreatic colon and stomach cancers cells at high levels where it is used as a tumor marker and presents an attractive molecular target.  sLea  facilitates tumor adhesion and extravasation that are key events for tumor metastasis, and thus presents a marker for the very cells that cause cancer recurrence.  Increased sLea expression on tumors is correlated with poor clinical outcome.  MabVax Therap
'/>"/>

SOURCE MabVax Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
11. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ... acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. ... of $28.10 in a cash and stock transaction valued at ... 31% to Auxilium,s closing price on September 16, 2014 and ... shares for the previous 30 days.  Under the terms of ...
(Date:9/16/2014)... Sept. 16, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... is commencing an underwritten registered public offering of ... shares are being offered by Aratana Therapeutics. ... as joint book-running managers for the offering.  ...
(Date:9/16/2014)... This report analyzes the worldwide markets for Foot Care Products ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
Breaking Medicine Technology:Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7Aratana Therapeutics, Inc. Announces Proposed Public Offering 2Global Foot Care Products Industry 2Global Foot Care Products Industry 3Global Foot Care Products Industry 4Global Foot Care Products Industry 5Global Foot Care Products Industry 6Global Foot Care Products Industry 7Global Foot Care Products Industry 8Global Foot Care Products Industry 9Global Foot Care Products Industry 10Global Foot Care Products Industry 11Global Foot Care Products Industry 12Global Foot Care Products Industry 13Global Foot Care Products Industry 14Global Foot Care Products Industry 15Global Foot Care Products Industry 16Global Foot Care Products Industry 17Global Foot Care Products Industry 18Global Foot Care Products Industry 19Global Foot Care Products Industry 20Global Foot Care Products Industry 21Global Foot Care Products Industry 22
(Date:9/17/2014)... Experienced dress company, Discount-Dress.com, announces that ... of trendy black bridesmaid dresses. Furthermore, the company has ... bridesmaid outfits. Readers can view more about ... is a famous brand of special occasion gowns ... well as revamped old editions, the supplier has set ...
(Date:9/17/2014)... 2014 Headquartered in Baltimore, Maryland, ... across the country. , “The past two weeks ... have grown to over 400 evaluators in 46 states, ... in the Midwest and South Dakota and Vermont. And ... where our volunteers can visit.” , TPU provides one-of-a-kind ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Request A ... lab testing, is offering 10% off drug testing ... to all drug tests, including those ordered by employers for ... take advantage of this discount by using promo code DRUG10 ... increase in positives on workplace drug testing, especially for marijuana ...
(Date:9/17/2014)... New York (PRWEB) September 17, 2014 ... together with experienced coaches to complete a three stage ... Adventure Team Challenge New York . , Hosted ... York’s Catskill Mountains, the 2014 Challenge includes five participating ... coaches for each athlete with disabilities will provide expert ...
(Date:9/17/2014)... 17, 2014 ICS Learning Group, Inc. ... Excellence in Training for the Best Use of Games ... on an online operational safety training module that ICS ... operation. Using an approach that combined realistic 3D ... that was similar to a video game, including competition ...
Breaking Medicine News(10 mins):Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3Health News:Request A Test Can Save You 10% on Drug Testing 2Health News:Request A Test Can Save You 10% on Drug Testing 3Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 3Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2
... As the connection between second-hand smoke and coronary heart ... reduce such passive smoking, exposures have been reduced. In ... the American Journal of Preventive Medicine , researchers ... Boston and Columbia University have recalibrated the CHD Policy ...
... Prior Year Quarter --, ... ... , TSX Venture Exchange: NVC , , ... specialty vascular device company, today announced financial results for the third quarter and ...
... - The Westaim Corporation today announced it has requisitioned ... to consider a return of capital to NUCRYST shareholders ... will continue to review alternatives to maximize the value ... the Alberta Business Corporations Act, NUCRYST,s Board of Directors ...
... nicotine use, personality illnesses common, study shows , , ... common among young adults in the United States, but ... reach this finding, U.S. researchers analyzed data from more ... part in the National Epidemiologic Survey on Alcohol and ...
... The Arthritis Foundation announces the 2008 winners of the ... The recipients, Dr. Gerard Karsenty of the Columbia University ... University received the award for their continued research advancements ... , Dr. Karsenty is recognized for his research in ...
... 1 Senetek PLC,(OTC Bulletin Board: SNKTY), a life ... the science of healthy aging,announced today that Dynamics Group ... and research with offices in Zurich,Bern and Geneva has ... The Research Report, available ...
Cached Medicine News:Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 2Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 3Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 4Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 5Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 6Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 7Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 8Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 9Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 10Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 11Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:Few Young Adults Seek Treatment for Psych Disorders 2
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Entire Column of a 384 Well Plate at ... 384 well plates, you need a pipettor that ... exactly what you get with our 16-channel Impact ... Impact/Impact2), this innovation was specifically designed to allow ...
... an Entire Column of a 384 Well Plate ... with 384 well plates, you need a pipettor ... Thats exactly what you get with our 16-channel ... (see Impact/Impact2), this innovation was specifically designed to ...
Medicine Products: